EUVIMEDEUVIMED entdecken
Fallbericht

Enteral Guanfacine to Treat Severe Anxiety and Agitation Complicating Critical Care After Cardiac Surgery

Habib Srour, Komal Pandya, Alex Flannery, Kevin Hatton

Seminars in Cardiothoracic and Vascular Anesthesia · 2018-12 · 22 (4) · 403-406

DOI: 10.1177/1089253218768537 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Seminars in Cardiothoracic and Vascular Anesthesia, online erschienen am 05.04.2018. Verfasst von Habib Srour und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 University of Kentucky, Lexington, KY, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article is the first reported case describing the off-label use of enteral immediate-release guanfacine, a long-acting α-2 adrenergic agonist most commonly used in the treatment of attention-deficit hyperactivity disorder, for sedation in a patient with severe anxiety and agitation limiting mechanical ventilation weaning several days after cardiac surgery. In this case, after several days of unsuccessful attempts to control his agitation and anxiety with conventional therapies, guanfacine therapy was initiated, and the patient was rapidly weaned from all other sedatives and mechanical ventilation shortly thereafter. The patient was weaned from guanfacine therapy without evidence of bradycardia, hypotension, or rebound syndrome. Enteral guanfacine therapy should be further studied as a potentially useful and cost-effective sedative therapy for patients with severe anxiety and/or agitation in the intensive care unit following cardiac and thoracic surgical procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic alpha-2 Receptor AgonistsAdultAnxietyCardiac Surgical ProceduresCritical CareGuanfacineHumansIntensive Care UnitsMalePsychomotor AgitationRespiration, ArtificialSeverity of Illness IndexVentilator Weaning

Stichwörter der Autor:innen

cognitive dysfunctioncritical careintensive care unitpostoperative carewithdrawal

Substanzen

Adrenergic alpha-2 Receptor AgonistsGuanfacine

Autor:innen und Institutionen

  • 1 University of Kentucky, Lexington, KY, USA.

Zitieren

APA

Srour, H., Pandya, K., Flannery, A., & Hatton, K. (2018). Enteral Guanfacine to Treat Severe Anxiety and Agitation Complicating Critical Care After Cardiac Surgery. Seminars in Cardiothoracic and Vascular Anesthesia, 22(4), 403-406. https://doi.org/10.1177/1089253218768537

Vancouver

Srour H, Pandya K, Flannery A, Hatton K. Enteral Guanfacine to Treat Severe Anxiety and Agitation Complicating Critical Care After Cardiac Surgery. Seminars in Cardiothoracic and Vascular Anesthesia. 2018;22(4):403-406. doi:10.1177/1089253218768537

BibTeX
@article{Srour2018,
  author = {Srour, Habib and Pandya, Komal and Flannery, Alex and Hatton, Kevin},
  title = {Enteral Guanfacine to Treat Severe Anxiety and Agitation Complicating Critical Care After Cardiac Surgery},
  journal = {Seminars in Cardiothoracic and Vascular Anesthesia},
  year = {2018},
  volume = {22},
  number = {4},
  pages = {403--406},
  doi = {10.1177/1089253218768537}
}
Kostenlos starten →